Search

Author/Creator Morano, F

1. RET fusions in a small subset of advanced colorectal cancers at risk of being neglected. (10th March 2018)

Authors:
Pietrantonio, F; Di Nicolantonio, F; Schrock, A B; Lee, J; Morano, F; Fucà, G; Nikolinakos, P; Drilon, A; Hechtman, J F; Christiansen, J; Gowen, K; Frampton, G M; Gasparini, P; Rossini, D; Gigliotti, C; Kim, S T; Prisciandaro, M; Hodgson, J; Zaniboni, A; Chiu, V K
Journal:
Annals of oncology
Issue:
Volume 29:Number 6(2018)
Page Start:
1394
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PD-016Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study. (2nd July 2019)

Authors:
Raimondi, A; Di Maio, M; Peverelli, G; Morano, F; Corallo, S; Bergamo, F; Cremolini, C; Smiroldo, V; Amatu, A; Tampellini, M; Fanchini, L; Murialdo, R; Clavarezza, M; Noventa, S; Adamo, V; Ratti, M; Petrelli, F; Antonuzzo, L; Palermo, M; de Braud, F
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. LBA-007Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC. (2nd July 2019)

Authors:
Cremolini, C; Antoniotti, C; Lonardi, S; Rossini, D; Morano, F; Cordio, S; Bergamo, F; Marmorino, F; Maiello, E; Passardi, A; Masi, G; Tamburini, E; Santini, D; Grande, R; Zaniboni, A; Granetto, C; Murgioni, S; Aprile, G; Delliponti, L; Boni, L
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. LBA22Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study. (23rd October 2018)

Authors:
Morano, F; Corallo, S; Di Bartolomeo, M; Lonardi, S; Cremolini, C; Rimassa, L; Sartore Bianchi, A; Murialdo, R; Zaniboni, A; Adamo, V; Tomasello, G; Tampellini, M; Fanchini, L; Schirripa, M; Clavarezza, M; Petrelli, F; Longarini, R; Cinieri, S; de Braud, F G M; Pietrantonio, F
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. O-016First-line FOLFOX plus panitumumab followed by 5-FU/LV plus panitumumab or single-agent panitumumab as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study. (20th June 2018)

Authors:
Pietrantonio, F; Morano, F; Corallo, S; Raimondi, A; Loupakis, F; Cremolini, C; Smiroldo, V; Berenato, R; Bianchi, A Sartore; Tampellini, M; Bustreo, S; Clavarezza, M; Murialdo, R; Zaniboni, A; Tomasello, G; Peverelli, G; Antoniotti, C; Procaccio, L; Cinieri, S; Antonuzzo, L
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PD-017Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC). (20th June 2018)

Authors:
Ongaro, E; Rossini, D; Pietrantonio, F; Morano, F; de Braud, F; Mazzaferro, V; Corti, F; Randon, G; Raimondi, A; Battaglia, L; Morelli, L; Urbani, L; Masi, G; Moretto, R; Antoniotti, C; Marmorino, F; Borelli, B; Zucchelli, G; Boccaccino, A; Cremolini, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. PD-008Molecular characterization of immune microenvironment in colorectal cancers with microsatellite instability by digital RNA counting. (20th June 2018)

Authors:
Giordano, M; Moretto, R; Giannini, R; Zucchelli, G; Pietrantonio, F; Antoniotti, C; Ugolini, C; Morano, F; Marmorino, F; Sensi, E; Belfiore, A; Rossini, D; Lupi, C; Masi, G; Borelli, B; Ongaro, E; Boccaccino, A; Falcone, A; Cremolini, C; Fontanini, G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. PD-008Molecular characterization of immune microenvironment in colorectal cancers with microsatellite instability by digital RNA counting. (20th June 2018)

Authors:
Giordano, M; Moretto, R; Giannini, R; Zucchelli, G; Pietrantonio, F; Antoniotti, C; Ugolini, C; Morano, F; Marmorino, F; Sensi, E; Belfiore, A; Rossini, D; Lupi, C; Masi, G; Borelli, B; Ongaro, E; Boccaccino, A; Falcone, A; Cremolini, C; Fontanini, G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. O-016First-line FOLFOX plus panitumumab followed by 5-FU/LV plus panitumumab or single-agent panitumumab as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study. (20th June 2018)

Authors:
Pietrantonio, F; Morano, F; Corallo, S; Raimondi, A; Loupakis, F; Cremolini, C; Smiroldo, V; Berenato, R; Bianchi, A Sartore; Tampellini, M; Bustreo, S; Clavarezza, M; Murialdo, R; Zaniboni, A; Tomasello, G; Peverelli, G; Antoniotti, C; Procaccio, L; Cinieri, S; Antonuzzo, L
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. Issue 12 (December 2022)

Authors:
Del Mastro, Lucia; Poggio, Francesca; Blondeaux, Eva; De Placido, Sabino; Giuliano, Mario; Forestieri, Valeria; De Laurentiis, Michelino; Gravina, Adriano; Bisagni, Giancarlo; Rimanti, Anita; Turletti, Anna; Nisticò, Cecilia; Vaccaro, Angela; Cognetti, Francesco; Fabi, Alessandra; Gasparro, Simon...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 12(2022)
Page Start:
1571
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗